advertisement
11.14 Investigational drugs; pharmacological experiments (112)
Showing records 1 to 25
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments70072 Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Skaat A
Journal of Glaucoma 2016; 25: e807-e814
69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Harris A
Journal of Glaucoma 2016; 25: e826-e833
70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Kimura A
Histology and Histopathology 2017; 32: 215-221
69863 Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-an
Babizhayev MA
BBA clinical 2016; 6: 49-68
70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Chao HM
Chinese medicine 2016; 11: 39
70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Ishimaru Y
Journal of Pharmacological Sciences 2017; 133: 34-41
70538 Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
Ren R
Investigative Ophthalmology and Visual Science 2016; 57: 6197-6209
70151 Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research
Rao PV
Experimental Eye Research 2017; 158: 23-32
70513 New classes of glaucoma medications
Schehlein EM
Current Opinions in Ophthalmology 2017; 28: 161-168
70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Cai X
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748
70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Van Bergen T
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439
70044 Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma
Lusthaus JA
Expert Opinion on Investigational Drugs 2016; 25: 1201-1208
70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Sakamoto K
European Journal of Pharmacology 2016; 791: 213-220
70466 Critical evaluation of latanoprostene bunod in the treatment of glaucoma
Garcia GA
Clinical Ophthalmology 2016; 10: 2035-2050
69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Laties A
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554
70557 Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma
Fonseca B
Purinergic signalling 2017; 13: 171-177
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Miller Ellis E
British Journal of Ophthalmology 2017; 101: 796-800
70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Terao E
Current Eye Research 2016; 0: 1-5
70838 The arguments for and against cannabinoids application in glaucomatous retinopathy
Panahi Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2017; 86: 620-627
70839 New furoxan derivatives for the treatment of ocular hypertension
Blangetti M
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483
70557 Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma
Martínez-Águila A
Purinergic signalling 2017; 13: 171-177
70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Murakami Y
European Journal of Pharmacology 2016; 791: 213-220
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Berlin MS
British Journal of Ophthalmology 2017; 101: 796-800
70151 Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research
Pattabiraman PP
Experimental Eye Research 2017; 158: 23-32
70839 New furoxan derivatives for the treatment of ocular hypertension
Rolando B
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483
